Razelle Kurzrock is the Founding Director of the Michels Rare Cancers Research Laboratories and a Professor of Medicine at the Medical College of Wisconsin. In addition to these roles, Kurzrock serves as a Board Member for CureMetrix and is part of the Executive Committee of the Board of Directors for the National Comprehensive Cancer Network® (NCCN®). Co-Founder and Board Member of CureMatch, Inc., Kurzrock also holds the position of Chair for Early Therapeutics and Rare Cancers within the SWOG Cancer Research Network and is a member of its Board of Governors. Razelle Kurzrock completed education at the University of Toronto, School of Medicine.